| 1 |
31983246 | Thymoquinone and curcumin combination protects cisplatin-induced kidney injury, nephrotoxicity by attenuating NFκB, KIM-1 and ameliorating Nrf2/HO-1 signalling. | 2020 Nov |
1 |
| 2 |
31258770 | MicroRNA-101-3p advances cisplatin sensitivity in bladder urothelial carcinoma through targeted silencing EZH2. | 2019 |
1 |
| 3 |
29505924 | LncRNA-MALAT1 contributes to the cisplatin-resistance of lung cancer by upregulating MRP1 and MDR1 via STAT3 activation. | 2018 May |
1 |
| 4 |
28053596 | Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathway. | 2017 |
1 |
| 5 |
27578576 | [Silencing MSH3 expression enhances cisplatin sensitivity of human tongue cancer cells]. | 2016 Aug 20 |
4 |
| 6 |
27900563 | LncRNA HOTAIR promotes cisplatin resistance in gastric cancer by targeting miR-126 to activate the PI3K/AKT/MRP1 genes. | 2016 Nov 30 |
1 |
| 7 |
23724141 | MSH3 mismatch repair protein regulates sensitivity to cytotoxic drugs and a histone deacetylase inhibitor in human colon carcinoma cells. | 2013 |
1 |
| 8 |
21285347 | MSH3 mediates sensitization of colorectal cancer cells to cisplatin, oxaliplatin, and a poly(ADP-ribose) polymerase inhibitor. | 2011 Apr 8 |
3 |
| 9 |
10470370 | Genomic amplification of the human DHFR/MSH3 locus remodels mismatch recognition and repair activities. | 1999 |
1 |